{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:00:57Z","timestamp":1786996857499,"version":"build-2736575974"},"reference-count":118,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Studies in History and Philosophy of Science Part C: Studies in History and Philosophy of Biological and Biomedical Sciences"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.shpsc.2011.05.005","type":"journal-article","created":{"date-parts":[[2011,6,24]],"date-time":"2011-06-24T23:01:44Z","timestamp":1308956504000},"page":"415-426","source":"Crossref","is-referenced-by-count":13,"title":["Blockbusters and controlled substances: Miltown, Quaalude, and consumer demand for drugs in postwar America"],"prefix":"10.1016","volume":"42","author":[{"given":"David","family":"Herzberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.shpsc.2011.05.005_b0005","first-page":"51","article-title":"Luding out","volume":"281","author":"Ager","year":"1972","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.shpsc.2011.05.005_b0010","series-title":"The truth about the drug companies: How they deceive us and what to do about it","author":"Angell","year":"2005"},{"key":"10.1016\/j.shpsc.2011.05.005_b0015","unstructured":"Axton, J. (n.d.). Survival information\u2014A report on Qs and Other meth drugs. Do It Now Foundation, 3(1)."},{"key":"10.1016\/j.shpsc.2011.05.005_b0020","unstructured":"Ayd, F. (1958). Testimony. False and Misleading Advertising (Prescription Tranquilizing Drugs). Hearings before the subcommittee on legal and marketing affairs of the committee on government operations, United States House of Representatives, February 11, 12, 24, 26. Washington: Government Printing Office."},{"key":"10.1016\/j.shpsc.2011.05.005_b0025","unstructured":"Barbanel, J. (1982). 2 Physicians get terms on \u201cDrug Resort\u201d charge. New York Times, August 27."},{"key":"10.1016\/j.shpsc.2011.05.005_b0030","unstructured":"Baumohl, J. (2004). Maintaining orthodoxy: The Depression-era struggle over morphine maintenance in California. In S. Tracy, & C.J. Acker (Eds.), Altering American consciousness: Essays on the history of alcohol and drug use in the United States, 1800\u20132000 (pp. 225\u2013266). Boston: University of Massachusetts Press."},{"key":"10.1016\/j.shpsc.2011.05.005_b0035","first-page":"1123","article-title":"Meprobamate: An adjunct to successful management of chronic headache","author":"Blumenthal","year":"1958","journal-title":"American Practitioner and Digest of Treatment"},{"key":"10.1016\/j.shpsc.2011.05.005_b0040","doi-asserted-by":"crossref","DOI":"10.1177\/002204267400400310","article-title":"The industry as pusher","author":"Bowes","year":"1974","journal-title":"Journal of Drug Issues"},{"key":"10.1016\/j.shpsc.2011.05.005_b0045","series-title":"Pharmaceutical marketing orientation seminar","first-page":"126","article-title":"Sales promotion","author":"Bradley","year":"1959"},{"issue":"2","key":"10.1016\/j.shpsc.2011.05.005_b0050","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1353\/tech.2005.0066","article-title":"Antibiotics, big business, and consumers: The context of government investigations into the postwar American drug industry","volume":"46","author":"Bud","year":"2005","journal-title":"Technology and Culture"},{"key":"10.1016\/j.shpsc.2011.05.005_b0055","series-title":"Penicillin: Triumph and tragedy","author":"Bud","year":"2007"},{"key":"10.1016\/j.shpsc.2011.05.005_b0060","year":"1958","journal-title":"Tranquil Pills Stir Up Doctors"},{"key":"10.1016\/j.shpsc.2011.05.005_b0065","unstructured":"Cameron, J. (1973). Pretty poison: A cold look at a hot drug. Potomac (Washington Post), February 11."},{"key":"10.1016\/j.shpsc.2011.05.005_b0075","series-title":"A consumers\u2019 republic","author":"Cohen","year":"2003"},{"key":"10.1016\/j.shpsc.2011.05.005_b0080","article-title":"The new nerve pills and your health","author":"Cooley","year":"1956","journal-title":"Cosmopolitan"},{"key":"10.1016\/j.shpsc.2011.05.005_b0085","series-title":"Impact of prescription drug diversion control systems on medical practice and patient care: NIDA research monograph 131","author":"Cooper","year":"1993"},{"key":"10.1016\/j.shpsc.2011.05.005_b0090","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.drugalcdep.2004.04.012","article-title":"The controlled substances act: How a \u201cbig tent\u201d reform became a punitive drug law","volume":"76","author":"Courtwright","year":"2004","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.shpsc.2011.05.005_b0095","unstructured":"Crosby, D. L., Burke, L. B., & Kennedy, J. S. (1978). Drug scheduling\u2014What effects? In Proceedings of the annual meeting of the American pharmaceutical association."},{"key":"10.1016\/j.shpsc.2011.05.005_b0100","series-title":"Pharmacopolitics: Drug regulation in the United States and Germany","author":"Daemmrich","year":"2004"},{"key":"10.1016\/j.shpsc.2011.05.005_b0105","series-title":"The cult of pharmacology: How America became the world\u2019s most troubled drug culture","author":"DeGrandpre","year":"2006"},{"key":"10.1016\/j.shpsc.2011.05.005_b0110","series-title":"Pharmaceutical marketing orientation seminar","first-page":"83","article-title":"Marketing","author":"DeTarnowsky","year":"1959"},{"key":"10.1016\/j.shpsc.2011.05.005_b0115","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1001\/jama.1957.02980240015004","article-title":"Twixt the cup and the lip","volume":"165","author":"Dowling","year":"1957","journal-title":"The Journal of the American Medical Association"},{"key":"10.1016\/j.shpsc.2011.05.005_b0120","unstructured":"Drake, D. (1973). \u201cPure Downer\u201d Tells life of drug use, abuse. Citizen Journal, May 23."},{"key":"10.1016\/j.shpsc.2011.05.005_b0125","unstructured":"Drug Awareness Warning Network. (1977\u20131981). Quarterly and annual reports. IMS America."},{"key":"10.1016\/j.shpsc.2011.05.005_b0130","series-title":"Psychedelic psychiatry: LSD from clinic to campus","author":"Dyck","year":"2008"},{"key":"10.1016\/j.shpsc.2011.05.005_b0135","first-page":"936","article-title":"Role of tranquilizing drugs in allergy","volume":"16","author":"Eisenberg","year":"1957","journal-title":"The Journal of the American Medical Association"},{"key":"10.1016\/j.shpsc.2011.05.005_b0140","series-title":"Methaqualone: A study of drug control","author":"Falco","year":"1975"},{"key":"10.1016\/j.shpsc.2011.05.005_b0145","unstructured":"Federal Register. (1972). Vol. 37, May 11, 9500."},{"key":"10.1016\/j.shpsc.2011.05.005_b0150","unstructured":"Federal Register. (1973a). Vol 38, April 11, 9170."},{"key":"10.1016\/j.shpsc.2011.05.005_b0155","unstructured":"Federal Register. (1973b). Vol 38, June 12, 15470."},{"key":"10.1016\/j.shpsc.2011.05.005_b0160","unstructured":"Federal Register. (1973c). Vol 37, October 4, 27517\u201327519."},{"key":"10.1016\/j.shpsc.2011.05.005_b0170","unstructured":"Federal Register. (1973\u20131980). Reports on federal methaqualone manufacturing limits: Vol. 39, March 12; Vol. 39, August 1; Vol. 39, December 13, 22851; Vol. 40, August 26, 37240; Vol. 42, May 6, 23212; Vol. 42, October 19, 55853; Vol. 43, May 12, 20565; Vol. 44, April 5, 72809; Vol. 44, July 6, 39627; Vol. 46, April 29, 24045\u201324046."},{"key":"10.1016\/j.shpsc.2011.05.005_b0175","unstructured":"Foster, M. (1963). In Smith, J., Foster, M., & Rudy, L. Tranquilizers and energizers\u2014or neither?\u201d Postgraduate Medicine, April 1963, 349."},{"key":"10.1016\/j.shpsc.2011.05.005_b0180","article-title":"A new drug brings relief for the tense and anxious","author":"Galton","year":"1955","journal-title":"Cosmopolitan"},{"key":"10.1016\/j.shpsc.2011.05.005_b0185","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1056\/NEJM195609132551112","article-title":"The play of the market place","volume":"255","author":"Garland","year":"1956","journal-title":"NEJM"},{"issue":"2","key":"10.1016\/j.shpsc.2011.05.005_b0190","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/09537320601168052","article-title":"Cultural enthusiasm, resistance and the societal embedding of new technologies: Psychotropic drugs in the 20th century","volume":"19","author":"Geels","year":"2007","journal-title":"Technology Analysis & Strategic Management"},{"key":"10.1016\/j.shpsc.2011.05.005_b0200","series-title":"Andean cocaine: The making of a global drug","author":"Gootenberg","year":"2009"},{"key":"10.1016\/j.shpsc.2011.05.005_b0205","unstructured":"Granik, T. (1960). American forum of the air. The Westinghouse Broadcasting Company, February 1 [in Senate Anti-Trust and Monopoly, Drugs, Accession 71A 5170, Box 19, Record Group 46, National Archives Building, Washington, DC.]."},{"key":"10.1016\/j.shpsc.2011.05.005_b0210","doi-asserted-by":"crossref","DOI":"10.2105\/AJPH.2009.181255","article-title":"Hidden in plain sight: The popular promotion of prescription drugs in the 20th century","author":"Greene","year":"2010","journal-title":"American Journal of Public Health"},{"issue":"2","key":"10.1016\/j.shpsc.2011.05.005_b0215","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1353\/bhm.0.0218","article-title":"Keeping modern in medicine: Pharmaceutical promotion and physician education in postwar America","volume":"83","author":"Greene","year":"2009","journal-title":"Bulletin of the History of Medicine"},{"key":"10.1016\/j.shpsc.2011.05.005_b0220","series-title":"The antidepressant era","author":"Healy","year":"1997"},{"key":"10.1016\/j.shpsc.2011.05.005_b0225","series-title":"The creation of psychopharmacology","author":"Healy","year":"2002"},{"key":"10.1016\/j.shpsc.2011.05.005_b0230","series-title":"Happy pills in America: From Miltown to Prozac","author":"Herzberg","year":"2009"},{"issue":"2","key":"10.1016\/j.shpsc.2011.05.005_b0235","first-page":"47","article-title":"\u201cWill wonder drugs never cease!\u201d: Direct-to-consumer marketing in the golden age of American medicine","volume":"51","author":"Herzberg","year":"2009","journal-title":"Pharmacy in History"},{"key":"10.1016\/j.shpsc.2011.05.005_b0240","series-title":"Protecting America\u2019s health: The FDA, business, and one hundred years of regulation","author":"Hilts","year":"2003"},{"key":"10.1016\/j.shpsc.2011.05.005_b0245","article-title":"Centers Hooked on Methaqualone","author":"Hoffman","year":"1981","journal-title":"New York Times"},{"key":"10.1016\/j.shpsc.2011.05.005_b0250","series-title":"The workings and philosophies of the pharmaceutical industry","first-page":"52","article-title":"Marketing concepts","author":"Hull","year":"1959"},{"issue":"11","key":"10.1016\/j.shpsc.2011.05.005_b0255","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1001\/jama.224.11.1505","article-title":"Methaqualone abuse: \u201cLuding out\u201d","volume":"224","author":"Inaba","year":"1973","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.shpsc.2011.05.005_b0260","first-page":"279","article-title":"Methaqualone abuse patterns, diversion paths and adverse reactions","volume":"61","author":"Inciardi","year":"1974","journal-title":"The Journal of the Florida Medical Association"},{"key":"10.1016\/j.shpsc.2011.05.005_b0265","series-title":"Food and drug legislation in the new deal","author":"Jackson","year":"1970"},{"issue":"1","key":"10.1016\/j.shpsc.2011.05.005_b0270","first-page":"47","article-title":"Before the drug culture: Barbiturate\/amphetamine abuse in American Society","volume":"11","author":"Jackson","year":"1976","journal-title":"Clio Medica"},{"key":"10.1016\/j.shpsc.2011.05.005_b0275","series-title":"Pharmaceutical marketing orientation seminar","first-page":"145","article-title":"Public relations","author":"Jenkins","year":"1959"},{"key":"10.1016\/j.shpsc.2011.05.005_b0280","unstructured":"Kline, N. (1958). Testimony. False and Misleading Advertising (Prescription Tranquilizing Drugs). Hearings before the Subcommittee on Legal and Marketing Affairs of the Committee on Government Operations, United States House of Representatives, February 11, 12, 24, 26. Washington: Government Printing Office."},{"key":"10.1016\/j.shpsc.2011.05.005_b0285","article-title":"New tranquilizing drugs","author":"Lemere","year":"1955","journal-title":"Northwest Medicine"},{"issue":"11","key":"10.1016\/j.shpsc.2011.05.005_b0290","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1001\/jama.224.11.1521","article-title":"Methaqualone","volume":"224","author":"Lewis","year":"1973","journal-title":"JAMA"},{"key":"10.1016\/j.shpsc.2011.05.005_b0295","series-title":"Medical science and medical industry: The formation of the American Pharmaceutical Industry","author":"Liebenau","year":"1987"},{"key":"10.1016\/j.shpsc.2011.05.005_b0300","unstructured":"Life. (1960). New Way to Calm a Cat, April 18, 93\u20135."},{"key":"10.1016\/j.shpsc.2011.05.005_b0305","article-title":"Trial opens for seven accused in sale of Quaalude at \u201cclinics\u201d","author":"Lubasch","year":"1982","journal-title":"New York Times"},{"key":"10.1016\/j.shpsc.2011.05.005_b0310","article-title":"6 Convicted of participation in Quaalude clinic scheme","author":"Lubasch","year":"1983","journal-title":"New York Times"},{"key":"10.1016\/j.shpsc.2011.05.005_b0315","article-title":"Nolle Nocere, Anxiety and Medicaments","author":"Maas","year":"1959","journal-title":"GP"},{"key":"10.1016\/j.shpsc.2011.05.005_b0320","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2105\/AJPH.85.1.109","article-title":"Revisiting \u201cthe origins of compulsory drug prescriptions\u201d","volume":"85","author":"Marks","year":"1995","journal-title":"American Journal of Public Health"},{"key":"10.1016\/j.shpsc.2011.05.005_b0610","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1177\/007327530003800304","article-title":"Trust and mistrust in the marketplace: Statistics and clinical research, 1945-1960","volume":"38","author":"Marks","year":"2000","journal-title":"History of Science"},{"key":"10.1016\/j.shpsc.2011.05.005_b0325","article-title":"Pressures on practitioners to prescribe tranquillizers","author":"Martin","year":"1960","journal-title":"Canadian Medical Association Journal"},{"key":"10.1016\/j.shpsc.2011.05.005_b0330","unstructured":"McFadyen, R. (1979). The FDA\u2019s regulation and control of antibiotics in the 1950s: The Henry Welch Scandal, F\u00e9lix Mart\u00ed-Ib\u00e1nez."},{"key":"10.1016\/j.shpsc.2011.05.005_b0615","series-title":"Prozac on the couch: Prescribing gender in the era of wonder drugs","author":"Metzl","year":"2003"},{"key":"10.1016\/j.shpsc.2011.05.005_b0335","series-title":"The American disease: The origins of narcotics control","author":"Musto","year":"1999"},{"key":"10.1016\/j.shpsc.2011.05.005_b0340","series-title":"The quest for drug control: Politics and federal policy in a period of increasing substance abuse, 1963\u20131981","author":"Musto","year":"2002"},{"key":"10.1016\/j.shpsc.2011.05.005_b0345","unstructured":"National Institute on Drug Abuse. (1973 E#1, 1977 E#7, 1978 E#12, 1979 E#17, 1981 E#25). Statistical Series Annual Data: Data From the Client Oriented Data Acquisitions Process. Washington: Alcohol, Drug Abuse, and Mental Health Administration of the Department of Health and Human Services."},{"key":"10.1016\/j.shpsc.2011.05.005_b0350","unstructured":"New York Times. (1981). Jury in Jersey Indicts 8 for Distributing drugs from a \u201cStress\u201d Center. March 14."},{"key":"10.1016\/j.shpsc.2011.05.005_b0355","unstructured":"Newsweek. (1956). Pills vs. worry\u2014How goes the frantic quest for calm in frantic lives? May 21, 68\u201370"},{"key":"10.1016\/j.shpsc.2011.05.005_b0360","unstructured":"Newsweek. (1973). Warning on \u201cSopors.\u201d February 12, 65."},{"key":"10.1016\/j.shpsc.2011.05.005_b0365","article-title":"There\u2019s gold in them there pills","author":"Ognibene","year":"1973","journal-title":"The New Republic"},{"key":"10.1016\/j.shpsc.2011.05.005_b0370","article-title":"\u201cStress\u201d centers use doctors to prescribe disputed drug","author":"Oreskes","year":"1981","journal-title":"New York Times"},{"key":"10.1016\/j.shpsc.2011.05.005_b0375","doi-asserted-by":"crossref","unstructured":"Orland, F. (1959) Use and Overuse of Tranquilizers. JAMA, October 10, 633\u20136.","DOI":"10.1001\/jama.1959.03010240001001"},{"key":"10.1016\/j.shpsc.2011.05.005_b0380","doi-asserted-by":"crossref","DOI":"10.1111\/j.1749-6632.1957.tb46013.x","article-title":"Treatment of anxiety states with meprobamate","author":"Osinski","year":"1957","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"4","key":"10.1016\/j.shpsc.2011.05.005_b0385","doi-asserted-by":"crossref","first-page":"607","DOI":"10.3109\/15563657308991060","article-title":"Methaqualone\u2014A Dr. Jekyll and Mr. Hyde?","volume":"6","author":"Ostrenga","year":"1973","journal-title":"Clinical Toxicology"},{"key":"10.1016\/j.shpsc.2011.05.005_b0390","doi-asserted-by":"crossref","unstructured":"Parry, H., Balter, M, Mellinger, G., Cisin, I., & Manheimer, D. (1973). National Patterns of Psychotherapeutic Drug Use. Archives of General Psychiatry, 28, 18\u201374.","DOI":"10.1001\/archpsyc.1973.01750360007002"},{"issue":"11","key":"10.1016\/j.shpsc.2011.05.005_b0395","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1001\/jama.224.11.1512","article-title":"Methaqualone abuse, the quiet epidemic","volume":"224","author":"Pascarelli","year":"1973","journal-title":"JAMA"},{"key":"10.1016\/j.shpsc.2011.05.005_b0400","article-title":"Unconsciousness expansion: The sopor story","author":"Perry","year":"1973","journal-title":"Rolling Stone"},{"issue":"1","key":"10.1016\/j.shpsc.2011.05.005_b0405","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3138\/cbmh.24.1.93","article-title":"\u201cFrom king kong pills to mother\u2019s little helpers\u2014career cycles of two families of psychotropic drugs: The barbiturates and benzodiazepines","volume":"24","author":"Pieters","year":"2007","journal-title":"Canadian Bulletin of Medical History"},{"issue":"1","key":"10.1016\/j.shpsc.2011.05.005_b0410","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1353\/bhm.2005.0036","article-title":"The drug industry and clinical research in interwar America: Three types of physician collaborator","volume":"79","author":"Rasmussen","year":"2005","journal-title":"Bulletin of the History of Medicine"},{"key":"10.1016\/j.shpsc.2011.05.005_b0415","series-title":"On speed: The many lives of amphetamine","author":"Rasmussen","year":"2008"},{"key":"10.1016\/j.shpsc.2011.05.005_b0420","unstructured":"Rasmussen, N. (forthcoming). Panic and the Prescriber: How the Politics of Amphetamine and Sedative Abuse Shaped Physician Authority over Pharmaceuticals Since 1940. In Watkins & Greene (Eds.), The Prescription in Perspective: Therapeutic Authority in Late 20th Century America. Baltimore, MD: Johns Hopkins University Press."},{"key":"10.1016\/j.shpsc.2011.05.005_b0425","article-title":"The use and abuse of the tranquilizers","author":"Rose","year":"1958","journal-title":"Canadian Medical Association Journal"},{"issue":"11","key":"10.1016\/j.shpsc.2011.05.005_b0430","first-page":"496","article-title":"Methaqualones \u201cheroin for lovers\u201d","volume":"14","author":"Russell","year":"1973","journal-title":"Journal of the Mississippi State Medical Association"},{"key":"10.1016\/j.shpsc.2011.05.005_b0435","unstructured":"Smith, A. (1960). Untitled essay. Rocky Mountain Medical Journal, March, 48, 49 [reprinted from a paper presented at the State Medical Journal Advertising Bureau, October 26, 1959 and located in Senate Anti-Trust and Monopoly, Drugs, Accession 71A 5170, Box 19, Record Group 46, National Archives Building, Washington, DC.]."},{"issue":"1","key":"10.1016\/j.shpsc.2011.05.005_b0440","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1353\/bhm.2006.0041","article-title":"On cannabis, chloral hydrate, and career cycles of psychotropic drugs in medicine","volume":"80","author":"Snelders","year":"2006","journal-title":"Bulletin of the History of Medicine"},{"key":"10.1016\/j.shpsc.2011.05.005_b0445","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.drugalcdep.2004.04.011","article-title":"Debating the controlled substances act","volume":"76","author":"Spillane","year":"2004","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.shpsc.2011.05.005_b0450","series-title":"Retail diversion of legal drugs: A major problem with no easy solution","author":"Staats","year":"1978"},{"key":"10.1016\/j.shpsc.2011.05.005_b0455","first-page":"55","article-title":"FDA and the practice of pharmacy: Prescription drug regulation before the Durham-Humphrey amendment of 1951","volume":"36","author":"Swann","year":"1994","journal-title":"Pharmacy in History"},{"key":"10.1016\/j.shpsc.2011.05.005_b0460","series-title":"Taking your medicine: Drug regulation in the United States","author":"Temin","year":"1980"},{"key":"10.1016\/j.shpsc.2011.05.005_b0465","unstructured":"Time. (1956). Don\u2019t-give-a-damn pills. February 27, 98."},{"key":"10.1016\/j.shpsc.2011.05.005_b0470","doi-asserted-by":"crossref","unstructured":"Time (1957). Happiness by Prescription, March 11, 59.","DOI":"10.1108\/eb011539"},{"key":"10.1016\/j.shpsc.2011.05.005_b0475","unstructured":"Time (1960). Tranquil but Alert, March 7, 47."},{"key":"10.1016\/j.shpsc.2011.05.005_b0480","unstructured":"Time. (1973). The Deadly Downer. March 5, 73."},{"issue":"4","key":"10.1016\/j.shpsc.2011.05.005_b0485","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1353\/bhm.0.0126","article-title":"Allied against reform: Pharmaceutical industry-academic physician relations in the United States, 1945\u20131970","volume":"82","author":"Tobbell","year":"2008","journal-title":"Bulletin of the History of Medicine"},{"issue":"4","key":"10.1016\/j.shpsc.2011.05.005_b0490","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1353\/bhm.2005.0173","article-title":"The great American Medicine show revisited","volume":"79","author":"Tomes","year":"2005","journal-title":"Bulletin of the History of Medicine"},{"key":"10.1016\/j.shpsc.2011.05.005_b0500","series-title":"Medicating modern America: Prescription drugs in history","first-page":"156","article-title":"Tranquilizers on trial: Psychopharmacology in the age of anxiety","author":"Tone","year":"2007"},{"key":"10.1016\/j.shpsc.2011.05.005_b0505","series-title":"The age of anxiety: A history of America\u2019s turbulent affair with tranquilizers","author":"Tone","year":"2008"},{"key":"10.1016\/j.shpsc.2011.05.005_b0510","series-title":"Altering American consciousness: Essays on the history of alcohol and drug use in the United States, 1800\u20132000","year":"2004"},{"key":"10.1016\/j.shpsc.2011.05.005_b0515","series-title":"Summary of Drug Control Actions under the Controlled Substances Act of 1970","year":"1977"},{"key":"10.1016\/j.shpsc.2011.05.005_b0520","unstructured":"US News and World Report. (1973). Latest drug danger: Another \u201crelaxer.\u201d April 22, 60."},{"key":"10.1016\/j.shpsc.2011.05.005_b0525","unstructured":"U.S. Senate. (1964). Committee on Government Operations, Subcommittee on Reorganization and International Organizations. Interagency Coordination in Drug Research and Regulation. Washington, D.C.: Government Printing Office."},{"key":"10.1016\/j.shpsc.2011.05.005_b0530","unstructured":"U.S. Senate. (1973). Methaqualone (Quaalude, Sopor) Traffic, Abuse, and Regulation. Subcommittee to Investigate Juvenile Delinquency of the Committee on the Judiciary, US Senate, 93rd Cong., 1st Sess. Washington, D.C.: GPO, 1973."},{"key":"10.1016\/j.shpsc.2011.05.005_b0535","unstructured":"U.S. Senate. (1982). Drug enforcement administration oversight and budget authorization and S. 2320. Subcommittee on Security and Terrorism of the Committee on the Judiciary, 97th Congress, 2nd. Sess., April 23. Washington: U.S. Government Printing Office."},{"key":"10.1016\/j.shpsc.2011.05.005_b0540","unstructured":"US v. Witt. (1982). 82-CR. 33-CSH."},{"issue":"August [Suppl.]","key":"10.1016\/j.shpsc.2011.05.005_b0545","first-page":"139","article-title":"Clinical experience with diazepam in general psychiatric practice","author":"Vilkin","year":"1962","journal-title":"Journal of Neuropsychiatry"},{"key":"10.1016\/j.shpsc.2011.05.005_b0555","series-title":"The estrogen elixir: A history of hormone replacement therapy in America","author":"Watkins","year":"2007"},{"key":"10.1016\/j.shpsc.2011.05.005_b0560","unstructured":"Weilburg, J. (1958). Risks and Rewards of Pharmaceutical Research. Smith Kline & French Laboratories [condensed by the company from The Bulletin of the Los Angeles County Medical Association, May 15, 1958, and located in Senate Anti-Trust and Monopoly, Drugs, Accession 71A 5170, Box 5, Record Group 46, National Archives Building, Washington, DC.]."},{"key":"10.1016\/j.shpsc.2011.05.005_b0565","unstructured":"Weissberg, K. (n.d.). Sopors are a bummer. Vibrations, 2(4)."},{"key":"10.1016\/j.shpsc.2011.05.005_b0570","article-title":"Getting there first with tranquility","author":"Whiteside","year":"1958","journal-title":"The New Yorker"},{"key":"10.1016\/j.shpsc.2011.05.005_b0575","unstructured":"Whorton, J.C. (1980) \u201cAntibiotic abandon\u201d: The resurgence of therapeutic rationalism. In Parascandola, J. (Ed.), The history of antibiotics (pp. 125\u201336). Madison: American Institute of the History of Pharmacy."},{"key":"10.1016\/j.shpsc.2011.05.005_b0580","article-title":"Quaalude advertisement","author":"Rorer","year":"1965","journal-title":"Medical World News"},{"issue":"1","key":"10.1016\/j.shpsc.2011.05.005_b0585","first-page":"55","article-title":"The facts behind the story: Pharmaceutical public relations","volume":"46","author":"Woodward","year":"1958","journal-title":"Bulletin of the Medical Library Association"},{"key":"10.1016\/j.shpsc.2011.05.005_b0590","series-title":"The toadstool millionaires: A social history of patent medicines in the United States before federal regulation","author":"Young","year":"1961"},{"key":"10.1016\/j.shpsc.2011.05.005_b0595","first-page":"59","article-title":"Federal drug and narcotic legislation","volume":"37","author":"Young","year":"1995","journal-title":"Pharmacy in History"},{"key":"10.1016\/j.shpsc.2011.05.005_b0600","article-title":"Sopors: Downs as a drug fad","author":"Zito","year":"1972","journal-title":"Washington Post"},{"key":"10.1016\/j.shpsc.2011.05.005_b0605","article-title":"Methaqualone: The \u201csafe\u201d drug that isn\u2019t very","author":"Zwerdling","year":"1972","journal-title":"Washington Post"}],"container-title":["Studies in History and Philosophy of Science Part C: Studies in History and Philosophy of Biological and Biomedical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1369848611000410?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1369848611000410?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T14:17:54Z","timestamp":1686147474000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1369848611000410"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":118,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S1369848611000410"],"URL":"https:\/\/doi.org\/10.1016\/j.shpsc.2011.05.005","relation":{},"ISSN":["1369-8486"],"issn-type":[{"value":"1369-8486","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}